Eli Lilly and Chugai jointly ventured by 50:50 in Japan.

Published: 1999-04-20 18:13:00

Updated: 1999-04-20 18:13:00

Eli Lilly and chugai Pharmaceutical announced plans to set up a 50: 50 joint venture in Japan called the Chugai Lilly Clinical Research Company. Based in Tokyo, the JV will manage the development of selected Lilly products targeted for the Japanese market and in return, Chugai will receive certai...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK